← Leaderboards
Moira Aitken
University Of Washington
$15,456
Attributed
$15,456
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$15,456 · 2
By mechanism
M01$15,456 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- David R Sherman$26,094,329
- Bonnie W Ramsey$21,623,756
- Thomas R Hawn$19,135,026
- Samuel I. Miller$34,128,042
- Alan A Aderem$59,360,862
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCystic FibrosisHuman SubjectEpidemiologyLung DisorderMetabolism Disorder ChemotherapyMycobacteriumOpportunistic InfectionsPharmacokineticsBacterial DiseaseRespiratory Disorder ChemotherapyClinical Trial Phase IDosage
Grant awards (4)
NONTUBERCULOUS MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS$3,864
M01 · FY2000 · RR
NONTUBERCULOUS MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS$3,864
M01 · FY2000 · RR
PHASE I TRIAL OF CPX IN ADULTS WITH MILD CYSTIC FIBROSIS$3,864
M01 · FY2000 · RR
PHASE I TRIAL OF CPX IN ADULTS WITH MILD CYSTIC FIBROSIS$3,864
M01 · FY2000 · RR